Inhibition of Bright function as a treatment for excessive immunoglobulin production

Details for Australian Patent Application No. 2005208766 (hide)

Owner Oklahoma Medical Research Foundation

Inventors Webb, Carol F.

Agent Pizzeys

Pub. Number AU-A-2005208766

PCT Pub. Number WO2005/072241

Priority 60/538,866 23.01.04 US

Filing date 21 January 2005

Wipo publication date 11 August 2005

International Classifications

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

24 August 2006 PCT application entered the National Phase

  PCT publication WO2005/072241 Priority application(s): WO2005/072241

18 December 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005208771-Facially amphiphilic polyaryl and polyarylalkynyl polymers and oligomers and uses thereof

2005208762-Cardiac monitoring